| Product Code: ETC7186931 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji continued to rely on imports for sterile injectable contract manufacturing, with top exporters being New Zealand, USA, Australia, India, and Taiwan, Province of China. The market remained highly concentrated, with a high Herfindahl-Hirschman Index (HHI). However, the industry experienced a significant decline in both compound annual growth rate (CAGR) and growth rate in 2024, indicating challenges and potential shifts in the market dynamics. This data suggests a need for further analysis to understand the factors contributing to the negative growth trends and potential implications for the industry in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Sterile Injectable Contract Manufacturing Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Sterile Injectable Contract Manufacturing Market - Industry Life Cycle |
3.4 Fiji Sterile Injectable Contract Manufacturing Market - Porter's Five Forces |
3.5 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.6 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.7 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By End-use Outlook, 2021 & 2031F |
4 Fiji Sterile Injectable Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Sterile Injectable Contract Manufacturing Market Trends |
6 Fiji Sterile Injectable Contract Manufacturing Market, By Types |
6.1 Fiji Sterile Injectable Contract Manufacturing Market, By Molecule Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Molecule Type, 2021- 2031F |
6.1.3 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.1.4 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.2 Fiji Sterile Injectable Contract Manufacturing Market, By Therapeutic Application |
6.2.1 Overview and Analysis |
6.2.2 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.2.4 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Central Nervous System Diseases, 2021- 2031F |
6.2.6 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Infectious Disorders, 2021- 2031F |
6.2.7 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3 Fiji Sterile Injectable Contract Manufacturing Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Subcutaneous (SC), 2021- 2031F |
6.3.3 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Intravenous (IV), 2021- 2031F |
6.3.4 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Intramuscular (IM), 2021- 2031F |
6.3.5 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Fiji Sterile Injectable Contract Manufacturing Market, By End-use Outlook |
6.4.1 Overview and Analysis |
6.4.2 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.4.3 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.4.4 Fiji Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Fiji Sterile Injectable Contract Manufacturing Market Import-Export Trade Statistics |
7.1 Fiji Sterile Injectable Contract Manufacturing Market Export to Major Countries |
7.2 Fiji Sterile Injectable Contract Manufacturing Market Imports from Major Countries |
8 Fiji Sterile Injectable Contract Manufacturing Market Key Performance Indicators |
9 Fiji Sterile Injectable Contract Manufacturing Market - Opportunity Assessment |
9.1 Fiji Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.2 Fiji Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
9.3 Fiji Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Fiji Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By End-use Outlook, 2021 & 2031F |
10 Fiji Sterile Injectable Contract Manufacturing Market - Competitive Landscape |
10.1 Fiji Sterile Injectable Contract Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Fiji Sterile Injectable Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here